Infectious Encephalitis: Clinical Trials

188 trials for Infectious Encephalitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

125 completed, 26 unknown, 15 recruiting, 6 not yet recruiting. 46 Phase 2, 44 Phase 3, 33 Phase 4, 17 Phase 1, 11 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 246Completed 27, Unknown 9, Recruiting 4, Terminated 3, Not yet recruiting 2, Active not recruiting 1
Phase 344Completed 39, Unknown 3, Not yet recruiting 1, Recruiting 1
Phase 433Completed 26, Unknown 5, Active not recruiting 1, Terminated 1
Phase 117Completed 9, Not yet recruiting 2, Terminated 2, Withdrawn 2, Recruiting 1, Unknown 1
Not applicable11Completed 6, Recruiting 2, Unknown 2, Not yet recruiting 1
Early Phase 12Completed 2

Follow Infectious Encephalitis: new trials by email Literature Review of Infectious Encephalitis trials Research Report on Infectious Encephalitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study
Brincidofovir - Progressive Multifocal Leukoencephalopathy
Phase 2RecruitingNational Institute of Neurological Disorders and Stroke (NINDS)242026-06-052026-07-22
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
Ozanimod - Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy
RecruitingBristol-Myers Squibb152026-06-042026-07-29
Clinical Features and Outcomes of VZV CNS Infections
Varicella Zoster, Varicella Meningitis
CompletedKocaeli University592026-04-172026-10-07
T-cell Therapy in Patients With PML
Application of T-lymphocytes - Progressive Multifocal Leucoencephalopathy (PML)
Phase 2RecruitingHannover Medical School232026-02-062026-10-15
First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.
Human monoclonal antibody TBE025, intravenous infusion - The Tick-borne Encephalitis Virus (TBEV)
Phase 1Not yet recruitingGiuseppe Pantaleo182026-01-012026-01-29
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus
Japanese Encephalitis
Not yet recruitingANRS, Emerging Infectious Diseases40002025-10-152025-09-11
A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers
V4020 - Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection
Phase 1Not yet recruitingMedigen, Inc.392025-08-152025-07-28
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
Plasma - West Nile Fever
Phase 2RecruitingGili Regev-Yochay MD372025-07-302025-08-26
FINtick - a Prospective Multicenter Study on Tick-borne Infections in Finland
Tick Borne Encephalitis (TBE), Lyme Borreliosis
RecruitingTurku University Hospital8502025-04-232026-10-27
Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus
Meningitis, Encephalitis Infection
Active not recruitingQIAGEN Gaithersburg, Inc15002025-04-032026-07-31
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
MVA-BN-WEV, Placebo - Encephalitis
Phase 2Active not recruitingBavarian Nordic4112025-03-102025-10-01
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Peripheral venous blood sample - Leishmaniasis, Leptospirosis
Not applicableNot yet recruitingUniversity Hospital, Montpellier1832025-03-032025-03-05
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
GBP560-A, GBP560-B, IXIARO - Japanese Encephalitis Virus Disease
Phase 1 / Phase 2CompletedSK Bioscience Co., Ltd.1612025-02-242026-09-11
Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas
Liaoning Chengda Inactivated Japanese Encephalitis Vaccine - Japanese Encephalitis
Phase 4Active not recruitingLiaoning Chengda Biotechnology CO., LTD2502024-11-142024-12-13
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)
Calculus bovis sativus (CBS) - Encephalitis, Encephalitis, Viral
Not applicableRecruitingTongji Hospital2502024-09-302025-04-08
Early Interferon-beta Treatment for West-Nile Virus Infection
Rebif 44 MCG Per 0.5 ML Prefilled Syringe, Saline - West Nile Virus, West Nile Fever Encephalitis
Phase 2UnknownTel-Aviv Sourasky Medical Center1002024-07-142024-07-23
Dexamethasone in Tick-borne Encephalitis
Dexametasone, Saline (0.9% NaCl) - Tick-Borne Encephalitis
Phase 3RecruitingUniversity Medical Centre Ljubljana2002024-05-032026-05-13
Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection
Pembrolizumab, 25 mg/ml solution for intravenous (IV) injection - Progressive Multifocal Leukoencephalopathy
Phase 2 / Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris332024-04-012024-02-26
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
Vero cell-drived inactive Japanese encephalitis vaccine, Measles-Mumps-Rubella Vaccine - Japanese Encephalitis, Measles
Phase 4CompletedLiaoning Chengda Biotechnology CO., LTD4082024-03-022025-08-28

Showing 20 of 188. Sign in to see all of them.

Narrower conditions

Encephalitis, Japanese (72)  ·  Encephalitis, Tick-Borne (51)  ·  Leukoencephalopathy, Progressive Multifocal (29)  ·  Encephalitis (17)  ·  West Nile Fever (12)  ·  Acquired Immunodeficiency Syndrome (8)  ·  Encephalomyelitis, Venezuelan Equine (8)  ·  Encephalitis, Viral (6)  ·  HIV Infections (6)  ·  Multiple Sclerosis (6)  ·  Measles (5)  ·  Meningitis (5)  ·  Rubella (5)  ·  Virus Diseases (5)  ·  Yellow Fever (5)

Broader conditions

Infections (188)  ·  Neuroinflammatory Diseases (188)  ·  Brain Diseases (187)  ·  Central Nervous System Infections (187)  ·  Central Nervous System Viral Diseases (186)  ·  Nervous System Diseases (186)  ·  Central Nervous System Diseases (185)  ·  Virus Diseases (182)  ·  Encephalitis, Viral (181)  ·  Encephalitis (171)  ·  RNA Virus Infections (157)  ·  Arbovirus Infections (147)  ·  Encephalitis, Arbovirus (147)  ·  Vector Borne Diseases (146)

Interventions

Japanese Encephalitis Vaccines (10)  ·  Vaccines (10)  ·  Blood Specimen Collection (5)  ·  Desiccation (3)  ·  Doxycycline (3)  ·  FSME-IMMUN vaccine (3)  ·  Hepatitis A Vaccines (3)  ·  Saline Solution (3)  ·  Surveys and Questionnaires (3)  ·  Dexamethasone (2)  ·  Didanosine (2)  ·  Immune Checkpoint Inhibitors (2)  ·  Measles-Mumps-Rubella Vaccine (2)  ·  Methylprednisolone (2)  ·  Natalizumab (2)

Sponsors

Pfizer (19)  ·  Valneva Austria GmbH (15)  ·  Sanofi Pasteur, a Sanofi Company (13)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (9)  ·  PATH (7)  ·  Sanofi (7)  ·  University Medical Centre Ljubljana (7)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (6)  ·  U.S. Army Medical Research and Development Command (6)  ·  Biogen (5)  ·  Novartis (5)  ·  Liaoning Chengda Biotechnology CO., LTD (3)  ·  Medical University of Vienna (3)  ·  National Institute of Hygiene and Epidemiology, Vietnam (3)  ·  Bavarian Nordic (2)

Countries

United States (46)  ·  Germany (23)  ·  Austria (17)  ·  France (12)  ·  China (11)  ·  Poland (9)  ·  Thailand (8)  ·  Australia (7)  ·  Philippines (7)  ·  Slovenia (7)  ·  Czechia (6)  ·  South Korea (5)  ·  Vietnam (5)  ·  Sweden (4)  ·  United Kingdom (4)

Top investigators

Irene CM Cortese, M.D. (4)  ·  Astrid Kaltenboeck, Ph.D. (3)  ·  Ryszard Konior, MD (3)  ·  Thiem D Vu, MD., PhD. (3)  ·  Anna Durbin, MD (2)  ·  Anthony Cardile, DO (2)  ·  Huanyu Wang (2)  ·  Jerzy Brzostek, MD (2)  ·  Jerzy Dziduch, MD (2)

Results publications

PMID 20934459, PMID 21592984, PMID 28545923, PMID 15714427, PMID 18190252, PMID 18394765, PMID 19143532, PMID 20856164, PMID 20864814, PMID 21148499, PMID 21150279, PMID 21288804, PMID 21398392, PMID 21738597, PMID 22696017, PMID 22777096, PMID 23733308, PMID 23967083, PMID 24656175, PMID 24687904, PMID 24717964, PMID 24873986, PMID 25149833, PMID 25232151, PMID 25239483, PMID 25308927, PMID 25483480, PMID 25567119, PMID 25728316, PMID 25872531, PMID 25886645, PMID 26005163, PMID 26994987, PMID 27206386, PMID 27628323, PMID 27686833, PMID 27815383, PMID 27903416, PMID 28135273, PMID 29081368, PMID 29325161, PMID 29429815, PMID 30304652, PMID 30833160, PMID 30928173, PMID 30962094, PMID 32156630, PMID 32474892, PMID 32528467, PMID 32728481

NIH funding

2005 (1), 2008 (1), 2009 (1), 2023 (1)